Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8201–8250 of 35180
On August 5, 2024, the Board of Directors of ALX Oncology Holdings Inc. (the “Company”) appointed Alan Sandler, M.D. to serve as a Class III director of the Board of Directors of the Company (the “Board”) for a term expiring at the 2026 annual meeting of stockholders
In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.
effective August 1, 2024, Jonathan Ireland has resigned from the Company’s Board of Directors
Upon recommendation of the Governance Committee, and effective as of August 1, 2024 (the “Effective Date”), Mr. Silva was appointed to the Board as the SPV’s designee to fill the vacancy created by Mr. Hoffman’s resignation.
Olav Bergheim and James L. Cox were appointed as Class I directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
Orly Mishan and Shahram Moaddeb were appointed as Class II directors
Olav Bergheim and James L. Cox were appointed as Class I directors
Orly Mishan and Shahram Moaddeb were appointed as Class II directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
Keyvan Mirsaeedi-Farahani, Timothy Moran and Sandra Gardiner were appointed as Class III directors
On August 6, 2024, the Nominating and Corporate Governance Committee of the Board nominated and the Board appointed Ms. Jia Yang as a vice president of the Company and as a director of the Board to fill the vacancy resulting from Mr. Haotian Song’s resignation.
On July 31, 2024, Mr. Haotian Song resigned from his position as a vice president of Singularity Future Technology Ltd. (the “ Company ”) and as a director of the board of directors of the Company (the “ Board ”).
On July 31, 2024, in connection with the IPO, Mr. Frederick Arnold and Mr. Benjamin Fader-Rattner were appointed to the board of directors of the Company
On July 31, 2024, in connection with the IPO, Mr. Frederick Arnold and Mr. Benjamin Fader-Rattner were appointed to the board of directors of the Company
the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board, effective August 5, 2024.
the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board, effective August 5, 2024.
Jerry Lewin resigned from his position as a member of the board of directors of the company on August 2, 2024, effective immediately.
On August 1, 2024, the Board of Trustees (the “Board”) of Nuveen Churchill Private Credit Fund (the “Company”) voted to increase the size of the Board from four (4) trustees to (5) trustees, and appointed Sarah Smith as a trustee effective August 1, 2024, to serve in such position until her successor is duly selected and qualified.
Effective August 1, 2024, Elizabeth Buchanan and Stephen Bowman were elected to the Board of Directors of Commonwealth Edison Company.
Effective August 1, 2024, Elizabeth Buchanan and Stephen Bowman were elected to the Board of Directors of Commonwealth Edison Company.
Lawrence W. Stranghoener provided notice to the Company that he does not intend to run for re-election to the Board at the Annual Meeting of Shareowners to be held in October 2024. He will retire from the Board at the end of that meeting.
On August 5, 2024, the Board of Directors (the “Board”) of PVH Corp. (the “Company”) appointed Kate Gulliver , 42, to the Board, effective immediately.
Appointment of New Director Effective July 31, 2024, the Board of Directors (the “Board”) of Johnson Controls International plc (the "Company") increased the size of the Board to 13 directors in accordance with its Memorandum and Articles of Association and appointed Patrick K . Decker to serve as a member of the Company’s Board
On August 1, 2024, Dr. Susan Altschuller notified Mural Oncology plc (the “Company”) of her decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees of the Board on which she serves, effective as of September 1, 2024.
the Board expanded its size from 11 directors to 12 directors and appointed Ms. Mikel A. Durham, former chief executive officer of American Seafoods Group, as a director, effective August 12, 2024.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
On July 30, 2024, the board of directors (the “Board”) of the Company appointed Charles McWherter, Ph.D. as a member of the Board.
On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.
On August 2, 2024, Gregory D. Ethridge resigned from the Board of Directors (the "Board") of Hennessy Capital Investment Corp. VI (the “Company”), effective immediately.
On August 4, 2024, the Company’s board of directors (“Board”) elected Daniel Wolf to serve as a director of the Company effective August 5, 2024, until his successor is elected and qualified, or sooner in the event of his death, resignation or removal.
On August 1, 2024, M2i Global, Inc. (“the Company”) appointed Anthony Short, a seasoned international business executive, to its Board of Directors, as a director.
On July 31, 2024, Marc Mazur, a Class III member of the Board of Directors of Celularity, notified the Board of Directors of his intention to resign as a member of the board and all committees thereof effective July 31, 2024.
The Board also appointed Mr. Penegor as a member of the Board with a term to last until the Company’s annual meeting of stockholders in 2025.
On August 5, 2024, the Board of Directors of Crane Company (the “Company”) elected Susan D. Lynch, 62, to serve as a Director for a term ending on the date of the next Annual Meeting of Stockholders in 2025.
On August 1, 2024, Anand Buch resigned as a director of Crexendo, Inc.
On August 5, 2024, the Company announced the appointment of Domenic Maida and Owen Wurzbacher to its Board of Directors (“Board”), effective as of August 6, 2024.
These appointments follow the resignation of Todd Crockett, which was received and became effective July 30, 2024.
On August 5, 2024, the Company announced the appointment of Domenic Maida and Owen Wurzbacher to its Board of Directors (“Board”), effective as of August 6, 2024.
On August 3, 2024, Vestis Corporation (the “Company”) announced that William W. Goetz was appointed to the Company’s Board of Directors (the “Board”) as a Class I director
On August 1, 2024, the Board appointed Martin Brand to the Board, effective as of August 1, 2024.
On July 30, 2024, Jennifer B. Morgan notified the Board of Directors (the “Board”) of Bumble Inc. (the “Company” or “Bumble”) of her decision to resign from the Board, effective as of July 30, 2024.
On July 31, 2024, Mr. Brian Protiva notified ADTRAN Holdings, Inc. (the “Company”) of his resignation from his role as a member of the Company’s Board of Directors (the “Board”), effective immediately.
Joanne M. Maguire notified the Company on July 29, 2024 of her decision to retire as a member of the Board, effective September 30, 2024
John M. Douglas has been appointed to the Board of Directors of the Company (the “Board”), effective September 30, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.